23/06/2023

INTRODUCING OCCLUNOVA: AN IMPLANTABLE DEVICE FOR CHRONIC ATRIAL FIBRILLATION (AF)

PRESS RELEASE June 23, 2023 Founded by NLC, OccluNova is developing an implantable LAA closure device for people with chronic atrial fibrillation (AF) Atrial…

Read more
12/06/2023

INTRODUCING THERAGENIX: GENE-BASED TISSUE REGENERATION

PRESS RELEASE June 12, 2023 TherageniX, an NLC venture, delivers genes for tissue repair and regeneration Disease, injuries and aging can damage body tissues….

Read more
20/03/2023

INTRODUCING PROVASCTEC : A CELL THERAPY FOR PATIENTS WITH CRITICAL LIMB ISCHEMIA

PRESS RELEASE March 20, 2023 ProVascTec, an NLC venture, will help patients  with critical limb ischemia by triggering cell induced new vascular tissue growth.   …

Read more
06/03/2023

INTRODUCING HEAT2MOVE: A NON-MEDICAL AND NON-INVASIVE PAIN RELIEVING TECHNOLOGY

PRESS RELEASE March 6, 2023 HEAT2MOVE, an NLC venture, sets out to provide a home care chronic pain relief option that is based on…

Read more
28/02/2023

INTRODUCING ANSANA: A NEW STERILIZATION TECHNOLOGY FOR THE HEALTHCARE & PHARMACEUTICAL INDUSTRY.

PRESS RELEASE February 28, 2023 Ansana, an NLC venture, is on a mission to develop and launch a cutting-edge system for observing and confirming…

Read more
27/02/2023

INTRODUCING CAREBED: A MOBILE-FRIENDLY SOLUTION FOR THE ELDERLY

PRESS RELEASE February 27, 2023 Carebed, an innovative bed that will increase a patient’s quality of life and reduce healthcare costs. Being dependent on…

Read more
23/02/2023

SERDA therapeutics submits IND

PRESS RELEASE February 23, 2023 SERDA therapeutics submits IND for its lead product, an innovative wound debridement agent. SERDA therapeutics, a biopharmaceutical company, announces…

Read more
15/02/2023

NC BIOMATRIX WINS EIC GRANT

PRESS RELEASE February, 15 2023 NC Biomatrix receives €2.5M European Innovation Council funding to complete pre-clinical studies and run its first-in-human trial Hundreds of…

Read more
15/02/2023

MINDAFFECT AWARDED EUROSTARS GRANT

PRESS RELEASE February 15, 2023 MindAffect awarded Eurostar Grant for MAHDs – a groundbreaking EEG based Hearing Diagnostic System With approximately 175 million disabled…

Read more
30/01/2023

NLC LAUNCHES FIRST IMPACT REPORT

PRESS RELEASE January 30, 2023 NLC is proud to announce their first Impact Report Regardless of their importance or creativity, 95% of all healthtech…

Read more
08/11/2022

INTRODUCING CONCORD BIRTH FLOW: BUILDING THE FUTURE OF CHILD BIRTH

PRESS RELEASE November 8, 2022 St. Antonius Hospital in the Netherlands leading the way with the Concord Birth Flow St. Antonius Hospital is the…

Read more
11/10/2022

MINDAFFECT SELECTED FOR POLE POSITION PROGRAMME

October 11, 2022 PRESS RELEASE MindAffect selected for Pole Position Programme – DeepTech/Medical field  MindAffect, a BCI/AI Healthtech company specializing in the development of…

Read more